Pacritinib-(VONJO)- (Feb 2022)- To treat intermediate or high risk primary or secondary primary myelofibrosis
Drug Name:Pacritinib-(VONJO)- (Feb 2022)- To treat intermediate or high risk primary or secondary primary myelofibrosis
List Of Brands:
Indication Type Description:
